Osimis Secures €2.3M Funding to Advance Medical Imaging Solutions and Reduce Patient Healthcare Costs

VCBeat (WeChat Official Account: vcbeat) learned from foreign media that on April 3, local time, Belgian biotechnology company Osimis completed a €2.3 million financing round, the specific stage of which was not disclosed. The funds raised will be used to further develop medical imaging equipment, aiming to reduce patients' medical costs and achieve interoperability of medical information across different regions.

It is reported that this round of financing was invested by an undisclosed team of medical technology experts.

Osimis, founded in 2015, is a biotechnology company dedicated to the research and development of medical imaging technologies. As a pioneer in the field of medical imaging, Osimis aims to expand its operations across Europe, North America, and Asia. Currently, the company’s flagship medical products are Osimis Pro Viewer and Lify. With annual revenues exceeding €500,000, Osimis serves clients in 14 countries and regions, collaborating with over 60 partner teams, including 22 hospitals.

Osimis Pro Viewer is the latest product from Osimis. As a medical imaging viewer, it leverages innovative technologies to enhance physicians' workflow efficiency and facilitate telemedicine data transmission. Osimis Pro Viewer addresses compatibility issues associated with legacy medical imaging equipment by offering a cross-platform solution that minimizes the steps required for physicians to switch between electronic displays. Furthermore, it incorporates 3D imaging technology, enabling comprehensive visualization of human anatomy from a single CT scan. During remote conferences among medical teams, Osimis Pro Viewer enables timely sharing of medical imaging data, thereby reducing the time spent on uploading information for meetings.

Lify is another medical imaging application from Osimis, dedicated to bringing clinical healthcare teams, medical specialists, teleradiologists, and patients together on a single platform for efficient medical diagnosis. Lify aims to strengthen collaboration among healthcare teams across different regions, improve the efficiency of information transmission and management, and integrate medical information resources from various locations. This innovative technology enhances the interoperability of medical information across distances and provides a platform for mutual learning among healthcare teams, contributing to further advancements in the medical field. When patients require transfer for treatment, the high level of connectivity ensures that hospitals in different regions have already received the patients’ CT data via the network. This not only helps reduce the time patients spend on redundant CT scans but also lowers medical costs. Currently, Lify offers remote sharing services for X-ray imaging, magnetic resonance imaging (MRI), and CT scans. Additionally, the Lify image viewer is compatible with various devices and can be accessed through any web browser.

Medical expert Sébastien Jodogne stated, “It is gratifying to see Osimis’s contributions to the field of medical imaging, which has entered a new historical phase.”

Frédéric Lambrechts, CEO of Osimis, stated, “This financing enables us to accelerate the further research and development of Osimis Pro Viewer and Lify, and supports the expansion of our business into international markets. Our goal is to enhance technologies for clinical diagnosis and optimize patient treatment pathways. Continuous technological advancement is our core objective, and we are currently recruiting computer scientists and specialized medical teams to meet the company’s growth needs.”

(Compiled by Liu Yujing)